Evolution and current practices in emergency contraceptives BY DR ALKA MUKHER...alka mukherjee
ey facts
Emergency contraception (EC) can prevent up to over 95% of pregnancies when taken within 5 days after intercourse.
EC can be used in the following situations: unprotected intercourse, concerns about possible contraceptive failure, incorrect use of contraceptives, and sexual assault if without contraception coverage.
Methods of emergency contraception are the copper-bearing intrauterine devices (IUDs) and the emergency contraceptive pills (ECPs).
A copper-bearing IUD is the most effective form of emergency contraception available.
The emergency contraceptive pill regimens recommended by WHO are ulipristal acetate, levonorgestrel, or combined oral contraceptives (COCs) consisting of ethinyl estradiol plus levonorgestrel.
Contraception Successes: IUDs and ImplantsSummit Health
Although unintended pregnancy rates in the United States have been static (approximately 51%) for many years, long-acting reversible contraception such as intrauterine devices (IUDs) and contraceptive implants may be reliable alternatives to prevent unwanted pregnancies and further lower unintended pregnancy rates. Join us to learn more about how long-acting reversible contraception may help you!
Evolution and current practices in emergency contraceptives BY DR ALKA MUKHER...alka mukherjee
ey facts
Emergency contraception (EC) can prevent up to over 95% of pregnancies when taken within 5 days after intercourse.
EC can be used in the following situations: unprotected intercourse, concerns about possible contraceptive failure, incorrect use of contraceptives, and sexual assault if without contraception coverage.
Methods of emergency contraception are the copper-bearing intrauterine devices (IUDs) and the emergency contraceptive pills (ECPs).
A copper-bearing IUD is the most effective form of emergency contraception available.
The emergency contraceptive pill regimens recommended by WHO are ulipristal acetate, levonorgestrel, or combined oral contraceptives (COCs) consisting of ethinyl estradiol plus levonorgestrel.
Contraception Successes: IUDs and ImplantsSummit Health
Although unintended pregnancy rates in the United States have been static (approximately 51%) for many years, long-acting reversible contraception such as intrauterine devices (IUDs) and contraceptive implants may be reliable alternatives to prevent unwanted pregnancies and further lower unintended pregnancy rates. Join us to learn more about how long-acting reversible contraception may help you!
Ovral-L (Ethinyl Estradiol and Levonorgestrel Tablets)Clearsky Pharmacy
Ovral-L (Ethinyl Estradiol and Levonorgestrel Tablets) is a combination hormone medication which is indicated for use by females of reproductive potential to prevent pregnancy. It is also used for the treatment of moderate acne vulgaris in women greater than 14 years of age who, have no known contraindications to oral contraceptive therapy, desire contraception, and have achieved menarche.
Ovral-L (Ethinyl Estradiol and Levonorgestrel Tablets)Clearsky Pharmacy
Ovral-L (Ethinyl Estradiol and Levonorgestrel Tablets) is a combination hormone medication which is indicated for use by females of reproductive potential to prevent pregnancy. It is also used for the treatment of moderate acne vulgaris in women greater than 14 years of age who, have no known contraindications to oral contraceptive therapy, desire contraception, and have achieved menarche.
Report on sexual activity and contraceptive methods for female ( June 2014)W&S Market Research
Research Method : Quantitative - Online research
Fieldwork Period : May 2014
Sample size : 1,776 samples
Research area : Vietnam Nationwide
Respondent Criteria :
Female aged 16 and above
Number of Questions :
5 Screening questions and 32 Main Questions
Survey Content :
Screening
Gender, Age, Occupation, Marital Status, Current Living City
Main Study
Sex and sexuality education, First sexual intercourse, Sex life in the last 3 months and contraceptive methods, Daily and Emergency contraceptive pills
Report on sexual activity and contraceptive methods for female
June 2014
Table of content
A.Research background
B.Research design
C.Respondent profile
D.Key findings
E.Detail findings
1. Frequently met women's health diseases
2. Sex knowledge
3. Sexual activity
4. Contraceptive methods
5. Daily contraceptive pills
6. Emergency contraceptive pills
Selection of an embryo from a large number of embryos and then placing it to the uterus is known as selective embryo transfer. This fertility preservation process is usually done after the process of IVF cycle and cancels the risks of spontaneous transfer of multiple embryos. Have a look at the detailed description of elective single embryo transfer in the following ppt.
Misconceptions about Oral Contraceptive Pill Used Among Women at Primary Heal...iosrjce
IOSR Journal of Nursing and health Science is ambitious to disseminate information and experience in education, practice and investigation between medicine, nursing and all the sciences involved in health care. Nursing & Health Sciences focuses on the international exchange of knowledge in nursing and health sciences. The journal publishes peer-reviewed papers on original research, education and clinical practice.
By encouraging scholars from around the world to share their knowledge and expertise, the journal aims to provide the reader with a deeper understanding of the lived experience of nursing and health sciences and the opportunity to enrich their own area of practice. The journal publishes original papers, reviews, special and general articles, case management etc.
Austin Journal of Women's Health is an open access, peer reviewed, scholarly journal dedicated to publish articles in all areas of women's healthcare including gynecology, obstetrics, and breast cancer and policies.
Austin Journal of Women's Health is committed to improving the health and health care of all women throughout the lifetime and in diverse communities with focus on the prevention, diagnosis and administration of fertility.
Austin Journal of Women's Health accepts original research articles, review articles, case reports, commentaries, clinical images and rapid communication on all the aspects of Women's Health.
Professor Soo Downe presenting at the Doctoral Midwifery Research Society Alcohol & Medication in Pregnancy Conferene about 'Which horse for which courses? The EBM Problem in studies of pharmacological substances in maternity care'.
An investigation of the proportion of unintended pregnancies and associated f...Gwinyai Masukume
The following presentation by fourth year medical students (as presented on October 27th 2007) won a prize in the best young presenter category at the University of Zimbabwe Annual Medical Research Day.
Challenges - In management of infertilityDrRokeyaBegum
Over fertility is a problem of Bangladesh.Still infertility is an issue 1 in 7 couples have difficulties to conceive.
Inability to create a desired pregnancy that culminates in the Birth of child is likely to create a life crisis for women and their partners.
4.8.4 AWHN Conference 6 2010 Theatrette Wool Store:Reproductive Health at Risk:
Challenges Associated with
Pelvic Inflammatory Disease
in remote Central Australia
4.8.2 AWHN Conference 6 2010 Theatrette Wool Store:IMPROVING WOMEN’S ACCESS TO HEALTH SERVICESTHE INNOVATIVE ROLE OF THE WOMEN’S HEALTH NURSE PRACTITIONER
4.1.4 AWHN Conference 6 2010 Federation Concert Hall: Cooperation and collaboration between NACCHO & AWHN and the Talking Circle. National Aboriginal Community ControlledHealthOrganisation.Aboriginal Community Controlled Health Service
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
3.4.2 Melissa Hobbs
1. Pharmacy access to the
emergency contraceptive
pill (ECP): women’s
knowledge, attitudes and
use
Melissa Hobbs, Angela Taft, Lisa Amir, Kay Stewart, Julia
Shelley, Anthony Smith, Colin Chapman, Safeera Hussainy
2. Collaboration
___________________________
•Research team:
- Angela Taft, Lisa Amir, Anthony Smith (La
Trobe University)
- Colin Chapman, Kay Stewart, Safeera
Hussainy (Monash University)
- Julia Shelley (Deakin University)
• Industry partners:
- Sexual Health & Family Planning Australia
- Bayer Schering Pharma
• Funded by ARC Linkage grant
3. Background
___________________________
• Rates of unplanned and unwanted pregnancies
in Australia are a public health concern
• Significantly higher teenage birth rate in
Australia (17.3 births per 1000 women)
compared with some other developed nations -
Japan (4.6), Switzerland (5.5), Korea (2.9)
(ABS, 2008; UNICEF, 2001)
• 17% of women aged 20-29 pregnant as a
teenager (Smith AMA et al., 2003)
Unintended pregnancy
4. Background
___________________________
• 23.8% of Australian men experienced condom
failure in previous 12 months (Smith AMA et al.,
2003)
• 53% of women 16-19 years at risk of unplanned
pregnancy used condoms as a contraceptive
method (Richters et al., 2003)
• Medical, emotional, social and financial impact of
unintended pregnancy is very significant
Unintended pregnancy (cont)
5. Background
___________________________
• Estimated that at least 50% of unintended
pregnancies end in abortion
• Australia’s estimated abortion rate (19.7 per
1000 females aged 15-44 years) is higher
compared with rates in Germany (7.7), The
Netherlands (8.7) or Finland (10.9)
(AIHW NPSU, 2005)
• Among women 16-59 years, 22.6% have had 1
or more abortions (Smith et al., 2003)
Abortion
6. Progestogen-only ECP
___________________________
• Available from health services with prescription
since July 2002
• Available over-the-counter (OTC) since January
2004
• Postinor 1 & 2, Levonelle 2 & Norlevo
• Since pharmacy access, very few population-
based studies on women’s knowledge, attitudes
and use
7. Study aim
___________________________
• To examine the provision of the ECP in
Australia – assess women’s
understanding, use, satisfaction with and
acceptance of the ECP, particularly since
OTC
11. Sampling (cont)
___________________________
• Stratified by state and territory
• Sample size calculated based on estimated
proportion of ECP use from 2 nationally
representative surveys:
•Australian Study of Health & Relationships
(ASHR) 2001/02 – 19.2% women 16-59
years ever used ECP
•Australian Longitudinal Study of Women’s
Health (ALSWH) 2006 – 9.8% women 28-33
years used ECP over previous 4 years
12. Results
___________________________
• Response rate 74.4%
• Sample weighted on basis of:
•household size (number of eligible women in
household)
•to match Australian population for age and
area of residence
14. Results: use
___________________________
• 26% (n=166) had ever used ECP
• 62% (n=100) of users obtained from pharmacy
• 68% (n=68) who obtained from pharmacy was
without prescription
• Largest subgroup (42%) used between ages 20-
24 years (n=68)
• 3% (n=5) used at age 14-15 years
• Majority (69%) used ECP only once (n=112)
15. Results: use (cont)
___________________________
• 70% said ECP was convenient to obtain
• Only 1 woman had supply of ECP at home for
future use
• Majority (79%) said it would be somewhat or
very easy to pay for ECP (about AUD $25)
• Main reason for non-use was did not think at risk
for pregnancy (57%)
16. Knowledge about ECP
Women n = 569
Statement about ECP True
n (%)
False
n (%)
Don’t Know
n (%)
ECP stops a pregnancy from starting 363 (63.7) 156 (27.4) 51 (8.9)
ECP is an abortion pill 181 (31.7) 354 (62.2) 35 (6.1)
ECP is also known as RU-486 98 (17.3) 144 (25.2) 327 (57.5)
You can take ECP up to 3 months after
becoming pregnant 10 (1.7) 504 (88.6) 55 (9.6)
You can’t get ECP at all in Australia 7 (1.3) 524 (92.0) 38 (6.7)
You can get ECP from a pharmacy without
a prescription 273 (48.0) 215 (37.7) 82 (14.4)
ECP can prevent you from getting an STD 5 (0.9) 553 (97.1) 11 (2.0)
ECP is more effective than regular
contraceptive pills at preventing pregnancy 55 (9.7) 446 (78.3) 68 (12.0)
After taking ECP you don’t need to use
contraception until your next period 1 (1.9) 527 (92.6) 31 (5.4)
17. Results: Knowledge and use
___________________________
0
10
20
30
40
1 2 3 4 5 6 7 8 9 10
Knowledge score
%
non-use
use
18. Women n = 525
n %
How safe is the ECP for the health of women?
Unsafe/very unsafe 93 17.7
Neither safe nor unsafe 153 29.1
Safe/very safe 237 45.2
Don’t know 41 7.9
How effective is the ECP at preventing pregnancy?
Ineffective/very ineffective 33 6.3
Neither effective nor ineffective 50 9.6
Effective/very effective 386 73.5
Don’t know 55 10.4
If a woman uses the ECP it will be harder for her to get pregnant in the future
Yes 67 12.7
No 356 67.7
Don’t know 103 19.6
If a woman does not know she is pregnant and uses the ECP, it will cause
problems such as birth defects or a miscarriage
Yes 318 60.5
No 78 14.8
Don’t know 129 24.5
Attitudes / beliefs about the ECP
19. Attitudes / beliefs about the ECP
Women n = 525
n %
When the ECP became available OTC from Australian pharmacies
in January 2004, it was a positive step for women
Disagree/strongly disagree 59 11.3
Neither agree nor disagree 90 17.1
Agree/strongly agree 373 71.1
Don’t know 2 0.4
The availability of the ECP will lead to more women having sex
without using contraception
Disagree/strongly disagree 238 45.4
Neither agree nor disagree 82 15.7
Agree/strongly agree 200 38.1
Don’t know 4 0.8
Men would be less likely to use a condom if they knew that their
female partners could get the ECP whenever they needed it
Disagree/strongly disagree 197 37.5
Neither agree nor disagree 102 19.5
Agree/strongly agree 224 42.6
Don’t know 2 0.4
20. Results: pharmacy experience
(n=68)
___________________________
• Of those who obtained ECP OTC, 62% said they
had enough privacy
• 24% were given contraceptive advice and 19%
given advice about sexually transmitted
infections (STIs) from pharmacist
• Less than half said it was pharmacist role to give
contraceptive (47%) and STI advice (49%)
21. Results: multivariate analysis
___________________________
• Women who believed OTC availability of ECP good step
for women significantly more likely to use ECP (OR 2.20;
95% CI 1.04 – 4.66)
• Women with ‘poor’ knowledge of ECP significantly less
likely to use ECP (OR 0.28; 95% CI 0.09 – 0.77)
• Women 20-29 years (OR 2.58; 95% CI 1.29 – 5.19) and
30-35 years (OR 3.16; 95% CI 1.47 – 6.80) more likely to
use ECP than women 16-19 years
• Women in de facto relationship (OR 2.21; 95% CI 1.27 –
3.85), in relationship but not living with partner (OR 2.46;
95% CI 1.31 – 4.63) or single (OR 2.40; 95% CI 1.33 –
4.34) more likely to use ECP than married women
22. Strengths and limitations
___________________________
• First national population-based Australian study
exploring women’s use of ECP
• CATI methodology has many advantages over
other data collection methods
• High usage of mobile phones in Australia and
‘mobile-only’ households more often younger
• Some groups of people excluded from telephone
surveys (homeless; those whose first language
is not English; those in institutions)
23. Conclusion
___________________________
• Women have high level of awareness of ECP
but inadequate specific knowledge
• More information and education required
• Relatively high prevalence of use of ECP in
Australia compared with other industrialised
countries
• Teenage women less likely to use ECP so
important to target this group